| Piyush Tiwari, MD | |
|
1188 Bishop St, 1102, Honolulu, HI 96813-3301 | |
| (808) 425-7718 | |
| (888) 369-9109 |
| Full Name | Piyush Tiwari |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 14 Years |
| Location | 1188 Bishop St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285951830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD17505 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piyush Tiwari Md Inc | 1759501935 | 2 |
News Archive
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Zcube, Srl, the research venture of Italian pharmaceutical company Zambon Co., SpA, and Arizona Technology Enterprises (AzTE), the technology venturing arm of Arizona State University, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices that can better monitor and treat chronic respiratory diseases like asthma.
The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.
Preoperative prostate magnetic resonance imaging (MRI) can help urologic surgeons spare the neurovascular bundle (NVB) (which controls a man's erectile function and continence) during a robotic assisted laparoscopic prostatectomy (RALP) for the treatment of prostate cancer, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.
› Verified 2 days ago
| Entity Name | Piyush Tiwari Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184038770 PECOS PAC ID: 1759501935 Enrollment ID: O20141010001016 |
News Archive
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Zcube, Srl, the research venture of Italian pharmaceutical company Zambon Co., SpA, and Arizona Technology Enterprises (AzTE), the technology venturing arm of Arizona State University, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices that can better monitor and treat chronic respiratory diseases like asthma.
The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.
Preoperative prostate magnetic resonance imaging (MRI) can help urologic surgeons spare the neurovascular bundle (NVB) (which controls a man's erectile function and continence) during a robotic assisted laparoscopic prostatectomy (RALP) for the treatment of prostate cancer, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Piyush Tiwari, MD 500 Ala Moana Blvd, 2200, Honolulu, HI 96813-4920 Ph: (808) 522-7500 | Piyush Tiwari, MD 1188 Bishop St, 1102, Honolulu, HI 96813-3301 Ph: (808) 425-7718 |
News Archive
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Zcube, Srl, the research venture of Italian pharmaceutical company Zambon Co., SpA, and Arizona Technology Enterprises (AzTE), the technology venturing arm of Arizona State University, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices that can better monitor and treat chronic respiratory diseases like asthma.
The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.
Preoperative prostate magnetic resonance imaging (MRI) can help urologic surgeons spare the neurovascular bundle (NVB) (which controls a man's erectile function and continence) during a robotic assisted laparoscopic prostatectomy (RALP) for the treatment of prostate cancer, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.
› Verified 2 days ago
Sohee Ki, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 4, Honolulu, HI 96813 Phone: 808-586-2903 | |
Dr. Robert C. Pedersen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2828 Paa St, Honolulu, HI 96819 Phone: 808-432-5777 | |
Dr. David H.f. Tom, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1100 Ward Ave, Suite 840, Honolulu, HI 96814 Phone: 808-522-4521 Fax: 808-522-3526 | |
Dr. Beau K. Nakamoto, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4000 Fax: 808-522-4437 | |
Dr. Christina S Hines, MD., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 459 Patterson Rd, Honolulu, HI 96819 Phone: 808-433-0320 | |
Daniel A. Alicata, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1356 Lusitana St, 4th Floor, Honolulu, HI 96813 Phone: 808-586-2900 | |
Angela Hu, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 4, Honolulu, HI 96813 Phone: 808-586-2903 |